Table 1.
Phenotype | Chrom | Position | LOD (P) | BCI (95%) | Closest marker | Flanking markers | EV | a | d | Action | Degree |
---|---|---|---|---|---|---|---|---|---|---|---|
A | 1 | 35.0 | 2.97 (0.019) | (24; 46) | Ace | Ace-ARC2 | 6.9 | 0.56 | −0.29 | PD | 0.52 |
2 | 62.0 | 12.29 (0.0001) | (57; 63) | NicPhRT | LF203-NicPhRT | 25.5 | 1.49 | 1.4 | D | 0.94 | |
3 | 58.8 | 3.37 (0.006) | (29; 68) | AC4 | AEDC1-AC4 | 7.8 | 0.65 | 0.4 | PD | 0.62 | |
B | 1 | 33.0 | 2.16 (0.126) | (5; 48) | Ace | B8L720-Ace | na | na | na | na | na |
2 | 63.0 | 26.43 (0.0001) | (62; 66) | NicPhRT | NicPhRT-AEG12 | 46.9 | 3.13 | 1.6 | PD | 0.51 | |
3 | 58.8 | 5.96 (0.0001) | (52; 63) | AC4 | AEDC1-AC4 | 13.3 | 1.39 | 0.93 | PD | 0.67 | |
C | 1 | 33.0 | 2.69 (0.046) | (22; 48) | Ace | B8L720-Ace | 6.2 | 0.83 | 0.65 | PD | 0.78 |
2 | 64.0 | 26.09 (0.0001) | (62; 66) | AEGI2 | NicPhRT-AEG12 | 46.5 | 2.86 | −0.02 | A | 0.01 | |
3 | 57.0 | 5.28 (0.0001) | (48; 63) | AC4 | AEDC1-AC4 | 11.9 | 1.39 | 0.76 | PD | 0.55 |
BCI, Bayes confidence interval; EV, estimated phenotypic variance explained; a, additive effect; d, dominance effect; Action, mode of action determined as d/a where additive = 0.0–0.20, partial dominance = 0.21–0.80, dominance = 0.81–1.20, and overdominance = >1.20 (after Stuber et al. 1987; Babu et al. 2006); Degree, d/a.